Notably, we observed an elevated occurrence of the ERBB2 p.Pro1170Ala variant in oligometastatic lung disease [14], and an absence of PIK3CA mutations in oligometastatic liver and lung disease [15]. This evidence concerns the gene ERBB2 and lung disorder.